Callos Andrew sold CYTK
May 1, 2026 · Form 4 insider transaction
Callos Andrew sold 15,857 shares of Cytokinetics, Incorporated at $65.00 per share, a transaction worth $1.03M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,857
Price
$65.00
Total value
$1.03M
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 1, 2026
Filing dateMay 4, 2026
Shares owned after58,555
OwnershipDirect
10b5-1 planNo
AmendedNo